Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Schedule Of Revision Of Previously Issued Financial Statements And Revenues To Correct The Misstatements

To correct the immaterial misstatement, the Company revised its previously issued financial statements as follows:

	As of March 31, 2022									As of December 31, 2021
CONSOLIDATED BALANCE SHEETS	As Previously Reported			Adjustments			As Revised			As Previously Reported			Adjustments			As Revised
Accrued expenses and other current liabilities	$	32,419		$	1,700		$	34,119		$	36,589		$	700		$	37,289
Total current liabilities	$	76,792		$	1,700		$	78,492		$	82,005		$	700		$	82,705
Total liabilities	$	193,044		$	1,700		$	194,744		$	201,224		$	700		$	201,924
Accumulated deficit	$	(60,046	)	$	(1,700	)	$	(61,746	)	$	(60,133	)	$	(700	)	$	(60,833	)
Total stockholders’ equity	$	243,228		$	(1,700	)	$	241,528		$	242,035		$	(700	)	$	241,335

	For the Three Months Ended March 31, 2022								For the Year Ended December 31, 2021
CONSOLIDATED STATEMENTS OF OPERATIONS	As Previously Reported		Adjustments			As Revised			As Previously Reported		Adjustments			As Revised
Net revenue	$	98,117	$	(1,000	)	$	97,117		$	468,059	$	(700	)	$	467,359
Gross profit	$	73,037	$	(1,000	)	$	72,037		$	353,860	$	(700	)	$	353,160
Income from operations	$	872	$	(1,000	)	$	(128	)	$	72,918	$	(700	)	$	72,218
Net income before income taxes	$	132	$	(1,000	)	$	(868	)	$	63,786	$	(700	)	$	63,086
Net income	$	87	$	(1,000	)	$	(913	)	$	94,902	$	(700	)	$	94,202

	Three Months Ended March 31, 2022									For the Year Ended December 31, 2021
CONSOLIDATED STATEMENTS OF CASH FLOWS	As Previously Reported			Adjustments			As Revised			As Previously Reported		Adjustments			As Revised
Net income / (loss)	$	87		$	(1,000	)	$	(913	)	$	94,902	$	(700	)	$	94,202
Changes in operating assets and liabilities:
Accrued expenses and other current liabilities	$	(4,828	)	$	1,000		$	(3,828	)	$	8,654	$	700		$	9,354

	Three Months Ended March 31, 2022							For the Year Ended December 31, 2021
Revenue by Product Category:	As Previously Reported		Adjustments			As Revised		As Previously Reported		Adjustments			As Revised
Advanced Wound Care	$	90,950	$	(860	)	$	90,090	$	430,839	$	(602	)	$	430,237
Surgical & Sports Medicine	$	7,167	$	(140	)	$	7,027	$	37,220	$	(98	)	$	37,122
Net revenue	$	98,117	$	(1,000	)	$	97,117	$	468,059	$	(700	)	$	467,359

	Three Months Ended March 31, 2022							For the Year Ended December 31, 2021
Miscellaneous Items	As Previously Reported		Adjustments			As Revised		As Previously Reported		Adjustments			As Revised
GPO fees	$	619	$	1,000		$	1,619	$	2,963	$	700		$	3,663
PuraPly revenue	$	53,300	$	(500	)	$	52,800	$	198,400	$	(350	)	$	198,050